Market closed
Orchestra BioMed Holdings, Inc./$OBIO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Orchestra BioMed Holdings, Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
Ticker
$OBIO
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
70
Website
OBIO Metrics
BasicAdvanced
$107M
-
-$1.66
0.59
-
Price and volume
Market cap
$107M
Beta
0.59
52-week high
$5.04
52-week low
$2.49
Average daily volume
564K
Financial strength
Current ratio
4.268
Quick ratio
4.128
Long term debt to equity
48.483
Total debt to equity
50.152
Interest coverage (TTM)
-216.50%
Management effectiveness
Return on assets (TTM)
-46.90%
Return on equity (TTM)
-120.84%
Valuation
Price to revenue (TTM)
38.804
Price to book
3.22
Price to tangible book (TTM)
3.22
Price to free cash flow (TTM)
-2.013
Growth
Revenue change (TTM)
-4.42%
Earnings per share change (TTM)
12.10%
3-year revenue growth (CAGR)
49.98%
3-year earnings per share growth (CAGR)
-46.63%
OBIO News
AllArticlesVideos
Orchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual Meeting
GlobeNewsWire·4 days ago
Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy
GlobeNewsWire·5 days ago
Orchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business Update
GlobeNewsWire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Orchestra BioMed Holdings, Inc. stock?
Orchestra BioMed Holdings, Inc. (OBIO) has a market cap of $107M as of April 27, 2025.
What is the P/E ratio for Orchestra BioMed Holdings, Inc. stock?
The price to earnings (P/E) ratio for Orchestra BioMed Holdings, Inc. (OBIO) stock is 0 as of April 27, 2025.
Does Orchestra BioMed Holdings, Inc. stock pay dividends?
No, Orchestra BioMed Holdings, Inc. (OBIO) stock does not pay dividends to its shareholders as of April 27, 2025.
When is the next Orchestra BioMed Holdings, Inc. dividend payment date?
Orchestra BioMed Holdings, Inc. (OBIO) stock does not pay dividends to its shareholders.
What is the beta indicator for Orchestra BioMed Holdings, Inc.?
Orchestra BioMed Holdings, Inc. (OBIO) has a beta rating of 0.59. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.